Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 192

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

2019 novel coronavirus disease (COVID‐19) in patients with inflammatory bowel diseases

Open access
Taxonera, Carlos, Sagastagoitia, Iñigo, Alba, Cristina, Mañas, Norberto, Olivares, David, Rey, Enrique · 2020 · Alimentary Pharmacology & Therapeutics

Abstract

Summary: Background: Data on patients with inflammatory bowel diseases (IBD) who have had 2019 novel coronavirus (SARS‐CoV‐2) disease (COVID‐19) are needed. Aims: To report the clinical characteristics, including gastrointestinal symptoms, of COVID‐19 in IBD patients, and to assess the risk of COVID‐19 in IBD. Methods: This case series included consecutive IBD patients with laboratory‐confirmed COVID‐19. Age‐adjusted cumulative incidences were compared with the general population in the Madrid region. Results: Through April 8, 12 of 1918 IBD patients were diagnosed with COVID‐19. The average age was 52 years, 75% of the patients were female and 58.3% had Crohn’s disease. Seven patients (58%) were on maintenance treatment with immunomodulators/biologics, of these four with combined therapy (33%). Eight patients (66%) required hospitalisation (one intensive care unit admission, and two deaths), and four patients were isolated at home. Nine patients had diarrhoea ranging between 4 and 10 loose stools per day (mean 5.4, SD 1.6). In five patients (42%) diarrhoea was a presenting symptom. In two patients, diarrhoea was the only symptom at debut. Cumulative incidence of COVID‐19 was 6.2 per 1000 IBD patients. IBD patients had a lower adjusted incidence ratio of COVID‐19 (OR 0.74, 95% CI 0.70‐0.77; P < 0.001), and a similar associated mortality ratio (OR 0.95, 95% CI: 0.84‐1.06; P = 0.36), compared with the general population. Conclusions: IBD patients do not have an increased risk of COVID‐19 and associated mortality compared with the general population. In many IBD patients, diarrhoea was a presenting symptom, and sometimes, was the only symptom at onset of COVID‐19.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/apt.15804

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 192

Metadata

Authors
Taxonera, C., Sagastagoitia, I., Alba, C., Mañas, N., Olivares, D., & Rey, E.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2020-06-07
Volume
52
Issue
2
Pages
276-283
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W3022587459
Cited by
192
References
1
FWCI
5.55
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 2019 novel coronavirus disease (COVID‐19) in patients with inflammatory bowel diseases. https://app.cochat.ai/papers/10.1111/apt.15804
The paper
Taxonera, C., Sagastagoitia, I., Alba, C., Mañas, N., Olivares, D., & Rey, E. (2020). 2019 novel coronavirus disease (COVID‐19) in patients with inflammatory bowel diseases. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.15804

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.